MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes.
Zhu Y, Chen P, Hu B, Zhong S, Yan K, Wu Y, Li S, Yang Y, Xu Z, Lu Y, Ouyang Y, Bao H, Gu W, Wen L, Zhang Y.
Zhu Y, et al. Among authors: li s.
Biomaterials. 2024 Jun;307:122533. doi: 10.1016/j.biomaterials.2024.122533. Epub 2024 Mar 13.
Biomaterials. 2024.
PMID: 38493671